Support AlterNet
Do you value the information you're getting from AlterNet? Please show your support with a tax-deductible donation.
Feedback
Tell us how we're doing.
Cronkite vs. O'Reilly: May the Most Trusted Man Win
Also in DrugReporter
The Supreme Court Resists Drug War Hysteria
Krystal Quinlan
This Is Your Country on Drugs: How the DARE Generation Got High
Ryan Grim
Michael Jackson Probably O.D.'d -- Just Like Thousands of Americans Who Fall Victim to Our Overdose Epidemic
Jill Harris
Rhode Island Will License Medical Marijuana Shops
Ryan Grim
Legal Pot in California in 2010? "Oaksterdam" Provides the Model
Don Hazen
No One Deserves to Die by Overdose
Jill Harris
Walter Cronkite, the legendary CBS news anchor widely dubbed "the most trusted man in America," has joined the legions of those who have earned the scorn of Fox News television host and commentator Bill O'Reilly -- and it's all about drugs. Or is it? While Cronkite's views on drug policy were what set O'Reilly off, the talk show host strayed far from the issue, touching on everything from Cronkite's age and mental condition to the evils of secular humanism.
Cronkite came up on O'Reilly's radar when he penned a fundraising letter for the Drug Policy Alliance, a nonpartisan group seeking a more humane approach to drug issues. "Today, our nation is fighting two wars: one abroad and one at home," Cronkite wrote. "While the war in Iraq is in the headlines, the other war is still being fought on our own streets. Its causalities are the wasted lives of our own citizens. I am speaking of the war on drugs."
In the letter, Cronkite explained his reasons for opposing the current drug war policies.
"And what is the impact of this policy? It surely hasn't made our streets safer. Instead, we have locked up literally millions of people … disproportionately people of color … who have caused little or no harm to others -- wasting resources that could be used for counter-terrorism, reducing violent crime or catching white-collar criminals.
"With police wielding unprecedented powers to invade privacy, tap phones and conduct searches seemingly at random, our civil liberties are in a very precarious condition," he added. "Hundreds of billions of dollars have been spent on this effort -- with no one held accountable for its failure."
For O'Reilly, attacking drug reform is a favorite pasttime, and he was on Cronkite like a hungry dog on a juicy bone. On the Feb. 24 edition of "The Factor," O'Reilly began by portraying Cronkite as "a very far-left guy" who lives "in the same left-wing precinct" as Bill Moyers and Tom Brokaw. Not to put too fine a point on it, said O'Reilly, Cronkite is "more far-left; he's always been that way, but he masked it."
It sounds like O'Reilly is still sore at Cronkite for telling national TV audiences the Vietnam War was a failure back in the late '60s. The fact that Cronkite is trying to help a group that has also received funds from current conservative bete noire George Soros probably doesn't help either. In addition to funding drug reform, the Hungarian-born currency speculator and financier worked hard to defeat President Bush in 2004, infuriating O'Reilly and his conservative colleagues, some of whom refer to him as that rarest of all creatures, the "left-wing billionaire."
"Anyway," O'Reilly continued, "he wants to legalize drugs." Actually, Cronkite didn't say that, but for the talk show host it's "truthiness" rather than truth that counts. Worse, said O'Reilly, Cronkite "lied" by saying the war on drugs had not made our streets safer. "That's not true; the war on drugs broke the back of the crack that was out of control in major cities all across the country," O'Reilly claimed.
What really happened to the "crack wars" is a matter of serious debate, with the role of law enforcement being only one of many factors. Researchers also point to learning curves -- a crackhead is not a very enticing role model -- and the consolidation of markets as key factors and, of course, the crack trade is still going strong.
Phillip Smith is an editor at DRCNet.
Liked this story? Get top stories in your inbox each week from DrugReporter! Sign up now »